18 January 2012 - Japanese drugmaker Takeda Pharmaceutical Company Limited (TYO:4502) announced plans on Wednesday to shed 2,800 jobs in Europe and the US and to consolidate its R&D facilities as part of efforts to restructure its international operations following last year's acquisition o...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up